Fangling Cheng

545 total citations
18 papers, 339 citations indexed

About

Fangling Cheng is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Fangling Cheng has authored 18 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Fangling Cheng's work include Glioma Diagnosis and Treatment (9 papers), Neuroblastoma Research and Treatments (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Fangling Cheng is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Neuroblastoma Research and Treatments (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Fangling Cheng collaborates with scholars based in China and United States. Fangling Cheng's co-authors include Dongsheng Guo, Baofeng Wang, Feng Mao, Yiju Wei, Wei Li, Qungen Xiao, Xingjiang Yu, Lei Zhang, Lijun Zhang and Guohao Liu and has published in prestigious journals such as Oncogene, Cancer Letters and Journal of the Neurological Sciences.

In The Last Decade

Fangling Cheng

17 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangling Cheng China 9 153 96 87 68 63 18 339
Maxim Sidorov United States 7 182 1.2× 72 0.8× 68 0.8× 117 1.7× 113 1.8× 9 328
Gyöngyi Kudlik Hungary 12 170 1.1× 51 0.5× 110 1.3× 88 1.3× 48 0.8× 15 363
Pucha Jiang China 12 194 1.3× 73 0.8× 74 0.9× 54 0.8× 16 0.3× 24 351
Emilie Denicolaï France 10 135 0.9× 72 0.8× 128 1.5× 100 1.5× 55 0.9× 17 324
Anant Vinjamoori United States 6 218 1.4× 91 0.9× 71 0.8× 138 2.0× 33 0.5× 7 425
Jennifer B. Edwards United States 8 284 1.9× 115 1.2× 113 1.3× 84 1.2× 48 0.8× 9 444
Samuel D. Rose United States 2 225 1.5× 171 1.8× 70 0.8× 57 0.8× 35 0.6× 2 407
Jinguen Rheey South Korea 7 215 1.4× 79 0.8× 67 0.8× 100 1.5× 18 0.3× 8 348
Federica Verginelli Italy 10 238 1.6× 93 1.0× 45 0.5× 85 1.3× 16 0.3× 14 347
Shi-Yuan Cheng United States 9 306 2.0× 148 1.5× 66 0.8× 95 1.4× 59 0.9× 9 412

Countries citing papers authored by Fangling Cheng

Since Specialization
Citations

This map shows the geographic impact of Fangling Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangling Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangling Cheng more than expected).

Fields of papers citing papers by Fangling Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangling Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangling Cheng. The network helps show where Fangling Cheng may publish in the future.

Co-authorship network of co-authors of Fangling Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Fangling Cheng. A scholar is included among the top collaborators of Fangling Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangling Cheng. Fangling Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chen, Xu, Yani Peng, Fangling Cheng, et al.. (2024). Survival Analysis of Patients Undergoing Intraoperative Contrast-enhanced Ultrasound in the Surgical Treatment of Malignant Glioma. Current Medical Science. 44(2). 399–405. 2 indexed citations
2.
Kong, Deguang, Fangling Cheng, Baoyuan Zhang, et al.. (2024). Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling. Biomarker Research. 12(1). 13–13. 15 indexed citations
4.
Cheng, Fangling, Pengcheng Li, Sanpeng Xu, et al.. (2024). A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines. Aging. 16(5). 4396–4422. 4 indexed citations
5.
Zhang, Yuxin, Yujie Zhang, Haisu Tao, et al.. (2023). Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy. Cancer Letters. 576. 216405–216405. 21 indexed citations
6.
Liu, Guohao, Po Zhang, Sui Chen, et al.. (2023). FAM129A promotes self-renewal and maintains invasive status via stabilizing the Notch intracellular domain in glioma stem cells. Neuro-Oncology. 25(10). 1788–1801. 11 indexed citations
7.
Peng, Peng, Hongtao Zhu, Dan Liu, et al.. (2022). TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling. Theranostics. 12(9). 4221–4236. 69 indexed citations
8.
Yang, Kaiping, et al.. (2022). Material basis and action mechanism of Euryale Ferox Salisb in preventing and treating diabetic kidney disease. Journal of Food Biochemistry. 46(12). e14409–e14409. 2 indexed citations
9.
Cheng, Fangling, Xueyan Wan, Baofeng Wang, et al.. (2022). Establishment and characteristics of GWH04, a new primary human glioblastoma cell line. International Journal of Oncology. 61(5). 3 indexed citations
10.
Peng, Peng, Fangling Cheng, Yuting Dong, et al.. (2021). High expression of TXNDC11 indicated unfavorable prognosis of glioma. Translational Cancer Research. 10(12). 5040–5051. 6 indexed citations
11.
Xiao, Qungen, Fangling Cheng, Po Zhang, et al.. (2020). Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling. Cancer Gene Therapy. 27(12). 878–897. 8 indexed citations
13.
Cheng, Fangling & Dongsheng Guo. (2019). MET in glioma: signaling pathways and targeted therapies. Journal of Experimental & Clinical Cancer Research. 38(1). 270–270. 110 indexed citations
14.
Cheng, Fangling, Po Zhang, Qungen Xiao, et al.. (2019). The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma. Frontiers in Oncology. 9. 447–447. 8 indexed citations
15.
Zhang, Lei, Fangling Cheng, Yiju Wei, et al.. (2018). Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells. Oncogene. 38(15). 2788–2799. 33 indexed citations
16.
Xiao, Qungen, Fangling Cheng, Feng Mao, et al.. (2018). LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells in vitro and in vivo through enhancing PDGFRβ signaling. International Journal of Oncology. 53(3). 1069–1082. 6 indexed citations
17.
Mao, Feng, Baofeng Wang, Qungen Xiao, et al.. (2017). LRIG proteins in glioma: Functional roles, molecular mechanisms, and potential clinical implications. Journal of the Neurological Sciences. 383. 56–60. 13 indexed citations
18.
Liu, Zhiwei, et al.. (2015). Vision Sensor Calibration Method based on Flexible 3d Target and Invariance of Cross Ratio. Advances in intelligent systems research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026